Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Cempra downgraded to Sell at Gabelli & Co; Final Nail in the Soli Coffin (4.20)Gabelli & Co downgrades CEMP to Sell from Hold. With CEMP shares trading in-line with 2016 year-end net cash, firm lowers their recommendation to Sell. The company is exploring strategic options, and they believe that the sum of the parts is greater than the current valuation if the company is able to formulate a successful liquidation plan in the next few months. <strong>However, without that catalyst, firm see little reason to own the stock.</strong> They expect the valuation to diminish along with the company's balance sheet over time. CEMP currently trades at a 12% premium to firm's 2017 PMV of $3.75 per share.</td> </tr></table>"